The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- G. Mckhann, D. Knopman, C. Phelps
- Medicine, PsychologyAlzheimer's & Dementia
- 1 May 2011
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
- B. Winblad, K. Palmer, R. Petersen
- Psychology, MedicineJournal of Internal Medicine
- 1 September 2004
A multidisciplinary, international group of experts discussed the current status and future directions of MCI, with regard to clinical presentation, cognitive and functional assessment, and the role of neuroimaging, biomarkers and genetics.
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- R. Sperling, P. Aisen, C. Phelps
- Psychology, BiologyAlzheimer's & Dementia
- 1 May 2011
The Alzheimer's disease neuroimaging initiative.
- S. Mueller, M. Weiner, L. Beckett
- Psychology, BiologyNeuroimaging clinics of North America
- 1 November 2005
NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease
- C. Jack, D. Bennett, R. Sperling
- BiologyAlzheimer's & Dementia
- 1 April 2018
The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
- C. Jack, M. Bernstein, M. Weiner
- BiologyJournal of Magnetic Resonance Imaging
- 1 April 2008
The approach taken in ADNI to standardization across sites and platforms of the MRI protocol, postacquisition corrections, and phantom‐based monitoring of all scanners could be used as a model for other multisite trials.
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- C. Jack, D. Knopman, J. Trojanowski
- Biology, PsychologyLancet Neurology
- 31 January 2010
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- C. Jack, D. Knopman, J. Trojanowski
- BiologyLancet Neurology
- 1 February 2013
The clinical use of structural MRI in Alzheimer disease
- G. Frisoni, Nick C Fox, C. Jack, P. Scheltens, P. Thompson
- Biology, PsychologyNature Reviews Neurology
- 1 February 2010
The utility of structural imaging and other markers will be increased by standardization of acquisition and analysis methods, and by development of robust algorithms for automated assessment, as well as by research into other imaging and nonimaging markers.
Automatic classification of MR scans in Alzheimer's disease.
- S. Klöppel, C. Stonnington, Richard S. J. Frackowiak
- MedicineBrain : a journal of neurology
- 1 March 2008
Assessment of support vector machines assigned individual diagnoses and whether data-sets combined from multiple scanners and different centres could be used to obtain effective classification of scans suggests an important role for computer based diagnostic image analysis for clinical practice.
...
...